Dynavax Technologies (DVAX) Gains from Sales and Divestitures: 2012-2023
Historic Gains from Sales and Divestitures for Dynavax Technologies (DVAX) over the last 11 years, with Dec 2023 value amounting to $1.5 million.
- Dynavax Technologies' Gains from Sales and Divestitures rose 22.66% to $1.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $1.7 million, marking a year-over-year increase of 22.66%. This contributed to the annual value of $1.5 million for FY2023, which is 26.78% up from last year.
- Dynavax Technologies' Gains from Sales and Divestitures amounted to $1.5 million in FY2023, which was up 26.78% from $1.2 million recorded in FY2022.
- In the past 5 years, Dynavax Technologies' Gains from Sales and Divestitures registered a high of $1.5 million during FY2023, and its lowest value of $537,000 during FY2021.
- In the last 3 years, Dynavax Technologies' Gains from Sales and Divestitures had a median value of $1.2 million in 2022 and averaged $1.1 million.
- Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first plummeted by 52.85% in 2021, then surged by 122.53% in 2022.
- Dynavax Technologies' Gains from Sales and Divestitures (Yearly) stood at $970,000 in 2019, then grew by 17.42% to $1.1 million in 2020, then crashed by 52.85% to $537,000 in 2021, then soared by 122.53% to $1.2 million in 2022, then climbed by 26.78% to $1.5 million in 2023.